Hiking With an Exoskeleton in 2026: What Actually Works on the Trail?
Compare six of the most credible exoskeletons for hiking and outdoor mobility in 2026, including current prices, weight, battery range, terrain suitability, evidence and key trade-offs.
CYBERDYNE Narrows Operating Loss as Medical HAL Fleet Reaches 570 Units
CYBERDYNE grew quarterly revenue to ¥1.027 billion and narrowed its operating loss to ¥17 million as its Medical HAL Lower Limb installed base reached 570 units worldwide.
Best Consumer Exoskeletons in 2026: Which One Is Right for You?
Compare the best consumer exoskeletons in 2026, including Hypershell, DNSYS and Ascentiz. See prices, use cases, key differences, independent evidence and what to consider before buying.
Ascentiz H Series Moves Into Commercial Sale
Ascentiz has moved its H Pro and H Ultra from early demonstrations into direct commercial sale. The bigger signal is not another exoskeleton announcement, but a consumer mobility product entering ordinary e-commerce with published pricing, fit ranges, returns and support.
Dephy Sidekick footwear expansion
Dephy’s latest Sidekick update is a footwear change rather than a new actuator, but that is precisely why it matters. In consumer exoskeletons, fit, comfort and how power reaches the ground can determine whether useful assistance survives real-world wear.
From Pilot to Daily Operations: What Logistics Exoskeleton Deployments Actually Show
Recent airport, warehouse and delivery initiatives show how exoskeleton programmes move from demonstration to operational use. This evidence-led analysis separates deployment signals from performance claims and explains what buyers should measure before scaling.